Hypoxia-inducible factor-1-dependent mechanisms of vascularization and vascular remodelling

被引:426
作者
Rey, Sergio [1 ,2 ]
Semenza, Gregg L. [1 ,2 ,3 ,4 ,5 ,6 ,7 ]
机构
[1] Johns Hopkins Univ, Sch Med, Inst Cell Engn, Vasc Program, Baltimore, MD 21205 USA
[2] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA
[3] Johns Hopkins Univ, Dept Pediat, Sch Med, Baltimore, MD 21205 USA
[4] Johns Hopkins Univ, Dept Med, Sch Med, Baltimore, MD 21205 USA
[5] Johns Hopkins Univ, Dept Oncol, Sch Med, Baltimore, MD 21205 USA
[6] Johns Hopkins Univ, Dept Radiat Oncol, Sch Med, Baltimore, MD 21205 USA
[7] Johns Hopkins Univ, Dept Biol Chem, Sch Med, Baltimore, MD 21205 USA
关键词
Angiogenesis; Cell therapy; Gene therapy; HIF-1; Hypoxia; Vascularization; ENDOTHELIAL GROWTH-FACTOR; CRITICAL LIMB ISCHEMIA; COLLATERAL ARTERY FORMATION; AGE-DEPENDENT IMPAIRMENT; FACTOR-I; GENE-EXPRESSION; TRANSCRIPTIONAL ACTIVITY; PULMONARY VASOCONSTRICTION; RETINAL NEOVASCULARIZATION; HIF-1-ALPHA SYNTHESIS;
D O I
10.1093/cvr/cvq045
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The vascular system delivers oxygen and nutrients to every cell in the vertebrate organism. Hypoxia-inducible factor 1 (HIF-1) is a master regulator of hypoxic/ischaemic vascular responses, driving transcriptional activation of hundreds of genes involved in vascular reactivity, angiogenesis, arteriogenesis, and the mobilization and homing of bone marrow-derived angiogenic cells. This review will focus on the pivotal role of HIF-1 in vascular homeostasis, the involvement of HIF-1 in vascular diseases, and recent advances in targeting HIF-1 for therapy in preclinical models.
引用
收藏
页码:236 / 242
页数:7
相关论文
共 100 条
[1]   SUPPRESSION OF RETINAL NEOVASCULARIZATION IN-VIVO BY INHIBITION OF VASCULAR ENDOTHELIAL GROWTH-FACTOR (VEGF) USING SOLUBLE VEGF-RECEPTOR CHIMERIC PROTEINS [J].
AIELLO, LP ;
PIERCE, EA ;
FOLEY, ED ;
TAKAGI, H ;
CHEN, H ;
RIDDLE, L ;
FERRARA, N ;
KING, GL ;
SMITH, LEH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (23) :10457-10461
[2]   VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells [J].
Asahara, T ;
Takahashi, T ;
Masuda, H ;
Kalka, C ;
Chen, DH ;
Iwaguro, H ;
Inai, Y ;
Silver, M ;
Isner, JM .
EMBO JOURNAL, 1999, 18 (14) :3964-3972
[3]   Therapeutic Angiogenesis in the Management of Critical Limb Ischemia Current Concepts and Review [J].
Attanasio, Steve ;
Snell, Jeffrey .
CARDIOLOGY IN REVIEW, 2009, 17 (03) :115-120
[4]   An abnormal mitochondrial-hypoxia inducible factor-1α-Kv channel pathway disrupts oxygen sensing and triggers pulmonary arterial hypertension in fawn hooded rats -: Similarities to human pulmonary arterial hypertension [J].
Bonnet, Sébastien ;
Michelakis, Evangelos D. ;
Porter, Christopher J. ;
Andrade-Navarro, Miguel A. ;
Thébaud, Bernard ;
Bonnet, Sandra ;
Haromy, Alois ;
Harry, Gwyneth ;
Moudgil, Rohit ;
McMurtry, Sean ;
Weir, E. Kenneth ;
Archer, Stephen L. .
CIRCULATION, 2006, 113 (22) :2630-2641
[5]   Effects of aging and hypoxia-inducible factor-1 activity on angiogenic cell mobilization and recovery of perfusion after limb ischemia [J].
Bosch-Marce, Marta ;
Okuyama, Hiroaki ;
Wesley, Jacob B. ;
Sarkar, Kakali ;
Kimura, Hideo ;
Liu, Ye V. ;
Zhang, Huafeng ;
Strazza, Marianne ;
Rey, Sergio ;
Savino, Lindsey ;
Zhou, Yi Fu ;
McDonald, Karin R. ;
Na, Youn ;
Vandiver, Scott ;
Rabi, Alireza ;
Shaked, Yuval ;
Kerbel, Robert ;
LaVallee, Theresa ;
Semenza, Gregg L. .
CIRCULATION RESEARCH, 2007, 101 (12) :1310-1318
[6]   Stabilization of HIF-1α is critical to improve wound healing in diabetic mice [J].
Botusan, Ileana Ruxandra ;
Sunkari, Vivekananda Gupta ;
Savu, Octavian ;
Catrina, Anca Irinel ;
Grunler, Jacob ;
Lindberg, Stina ;
Pereira, Teresa ;
Yla-Herttuala, Seppo ;
Poellinger, Lorenz ;
Brismar, Kerstin ;
Catrina, Sergiu-Bogdan .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (49) :19426-19431
[7]   Cellular and molecular basis of wound healing in diabetes [J].
Brem, Harold ;
Tomic-Canic, Marjana .
JOURNAL OF CLINICAL INVESTIGATION, 2007, 117 (05) :1219-1222
[8]   Ranibizumab versus verteporfin for neovascular age-related macular degeneration [J].
Brown, David M. ;
Kaiser, Peter K. ;
Michels, Mark ;
Soubrane, Gisele ;
Heier, Jeffrey S. ;
Kim, Robert Y. ;
Sy, Judy P. ;
Schneider, Susan .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (14) :1432-1444
[9]   SDF-1 is both necessary and sufficient to promote proliferative retinopathy [J].
Butler, JM ;
Guthrie, SM ;
Koc, M ;
Afzal, A ;
Caballero, S ;
Brooks, HL ;
Mames, RN ;
Segal, MS ;
Grant, MB ;
Scott, EW .
JOURNAL OF CLINICAL INVESTIGATION, 2005, 115 (01) :86-93
[10]   Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions [J].
Carmeliet, P ;
Moons, L ;
Luttun, A ;
Vincenti, V ;
Compernolle, V ;
De Mol, M ;
Wu, Y ;
Bon, F ;
Devy, L ;
Beck, H ;
Scholz, D ;
Acker, T ;
DiPalma, T ;
Dewerchin, M ;
Noel, A ;
Stalmans, I ;
Barra, A ;
Blacher, S ;
Vandendriessche, T ;
Ponten, A ;
Eriksson, U ;
Plate, KH ;
Foidart, JM ;
Schaper, W ;
Charnock-Jones, DS ;
Hicklin, DJ ;
Herbert, JM ;
Collen, D ;
Persico, MG .
NATURE MEDICINE, 2001, 7 (05) :575-583